000 | 00920 a2200289 4500 | ||
---|---|---|---|
005 | 20250517055926.0 | ||
264 | 0 | _c20180222 | |
008 | 201802s 0 0 eng d | ||
022 | _a1464-410X | ||
024 | 7 |
_a10.1111/bju.13352 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWarren, Hannah | |
245 | 0 | 0 |
_aPioglitazone and bladder cancer. _h[electronic resource] |
260 |
_bBJU international _c07 2016 |
||
300 |
_a16-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Comment | ||
650 | 0 | 4 | _aDiabetes Mellitus, Type 2 |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHypoglycemic Agents |
650 | 0 | 4 | _aPioglitazone |
650 | 0 | 4 | _aThiazolidinediones |
650 | 0 | 4 | _aUrinary Bladder Neoplasms |
700 | 1 | _aRaison, Nicholas | |
700 | 1 | _aDasgupta, Prokar | |
773 | 0 |
_tBJU international _gvol. 118 _gno. 1 _gp. 16-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bju.13352 _zAvailable from publisher's website |
999 |
_c25356225 _d25356225 |